111 related articles for article (PubMed ID: 3127078)
1. Biochemical determinants of clearance of tissue-type plasminogen activator from the circulation.
Lucore CL; Fry ET; Nachowiak DA; Sobel BE
Circulation; 1988 Apr; 77(4):906-14. PubMed ID: 3127078
[TBL] [Abstract][Full Text] [Related]
2. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
3. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
[TBL] [Abstract][Full Text] [Related]
5. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
Stang E; Roos N; Schlüter M; Berg T; Krause J
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
[TBL] [Abstract][Full Text] [Related]
6. Hepatic membrane receptors for glycoproteins.
Steer CJ; Ashwell G
Prog Liver Dis; 1986; 8():99-123. PubMed ID: 2940622
[No Abstract] [Full Text] [Related]
7. Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver.
Otter M; Kuiper J; van Berkel TJ; Rijken DC
Ann N Y Acad Sci; 1992 Dec; 667():431-42. PubMed ID: 1339243
[No Abstract] [Full Text] [Related]
8. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
Warshawsky I; Bu G; Schwartz AL
J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
[TBL] [Abstract][Full Text] [Related]
9. Role of mannose/N-acetylglucosamine receptors in blood clearance and cellular attachment of Leishmania donovani.
Chakraborty P; Das PK
Mol Biochem Parasitol; 1988 Feb; 28(1):55-62. PubMed ID: 3374526
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat.
Larsen GR; Metzger M; Henson K; Blue Y; Horgan P
Blood; 1989 May; 73(7):1842-50. PubMed ID: 2496774
[TBL] [Abstract][Full Text] [Related]
11. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
[TBL] [Abstract][Full Text] [Related]
12. Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
Lansink M; Jong M; Bijsterbosch M; Bekkers M; Toet K; Havekes L; Emeis J; Kooistra T
Blood; 1999 Aug; 94(4):1330-6. PubMed ID: 10438721
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
[TBL] [Abstract][Full Text] [Related]
14. Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor.
Noorman F; Barrett-Bergshoeff MM; Rijken DC
Eur J Biochem; 1998 Jan; 251(1-2):107-13. PubMed ID: 9492274
[TBL] [Abstract][Full Text] [Related]
15. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
Lucore CL; Fujii S; Sobel BE
Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
Rijken DC; Otter M; Kuiper J; van Berkel TJ
Thromb Res Suppl; 1990; 10():63-71. PubMed ID: 2107599
[TBL] [Abstract][Full Text] [Related]
17. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator.
Hotchkiss A; Refino CJ; Leonard CK; O'Connor JV; Crowley C; McCabe J; Tate K; Nakamura G; Powers D; Levinson A
Thromb Haemost; 1988 Oct; 60(2):255-61. PubMed ID: 2851193
[TBL] [Abstract][Full Text] [Related]
18. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.
Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J
Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415
[TBL] [Abstract][Full Text] [Related]
19. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
[TBL] [Abstract][Full Text] [Related]
20. Binding of tissue-type plasminogen activator by the mannose receptor.
Otter M; Barrett-Bergshoeff MM; Rijken DC
J Biol Chem; 1991 Jul; 266(21):13931-5. PubMed ID: 1906888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
